New SEC Form D filing
NewcelX Ltd., 2026-11-18
A new SEC Form D private-offering notice from Kloten, a $2,875,023 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
NewcelX Ltd. Verified via SEC Form D
New filing yesterdayFiled to raise $2,875,023First money in 2026-11-09Raised so far $2,875,023HQ (as filed) KlotenSector Biotech machine-classified from the filing aloneStage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Galvanize Therapeutics, Inc., 2026-11-18, $136.2M, Redwood City, CA
- Kura Oncology, Inc., 2026-11-18, $25M, San Diego, CA
- Ansa Biotechnologies, Inc., 2026-11-18, $71.9M, Emeryville, CA
- Vesalius Longevity Labs Inc., 2026-11-18, $13.5M, Vancouver, BC, Canada
- Human Biotech, Inc., 2026-11-17, $10M, Cambridge, MA
- UCHU Biosensors, Inc., 2026-11-17, $6M, Newark, NJ
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.